Multinational Survey of Epidemiology, Morbidity, and Outcomes in Intracerebral Hemorrhage

NCT ID: NCT02567162

Last Updated: 2016-12-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-11-30

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this project is development of a comprehensive, prospective, multinational, multicenter, hospital-based, data repository for patients with intracerebral hemorrhage.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

MNEMONICH is a disease-specific registry of prospectively collected data obtained from the integration and harmonization of preexisting single-center data sets. It was formed to provide clinician-scientists around the world a comprehensive database to direct future studies toward better understanding of ICH. MNEMONICH will help examine global variability in the prevalence of ICH and identify research priorities.

New data for MNEMONICH will be prospectively collected on a wide range of features including demographics, medical history, dates and times of symptom onset, presentation symptoms, hemodynamic signs, initial and chronic medical therapy, diagnostic imaging, laboratory and genetic analyses, pathological data, and surgical and medical management. Future research will be based upon ad hoc analysis of this data.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracerebral Hemorrhage

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Intracerebral hemorrhage Hemorrhagic stroke Intraparenchymal hemorrhage Cerebrovascular disease Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of spontaneous intracerebral hemorrhage (ICH) met by clinical and imaging criteria
* Age 18 and above
* Able to consent

Exclusion Criteria

* ICH due to trauma
* ICH due to vascular malformation or aneurysm
* ICH due to brain tumor
* ICH due to underlying infectious lesion (e.g., abscess)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre for Cardiovascular Medicine and Cerebrovascular Disease Prevention

UNKNOWN

Sponsor Role collaborator

Hospital Interzonal de Agudos San Juan Bautista

OTHER

Sponsor Role collaborator

Maastricht University Medical Center

OTHER

Sponsor Role collaborator

University of Western Ontario, Canada

OTHER

Sponsor Role collaborator

Northern Care Alliance NHS Foundation Trust

OTHER

Sponsor Role collaborator

University of Manchester

OTHER

Sponsor Role collaborator

University of Rostock

OTHER

Sponsor Role collaborator

University of Medicine and Pharmacy Craiova

OTHER

Sponsor Role collaborator

San Camillo de' Lellis General Hospital

OTHER

Sponsor Role collaborator

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV

Sponsor Role collaborator

University of Central Florida

OTHER

Sponsor Role collaborator

Manchester Metropolitan University

OTHER

Sponsor Role collaborator

The University of Texas Health Science Center at San Antonio

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Reza Behrouz

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mario Di Napoli, MD

Role: STUDY_DIRECTOR

Centre for Cardiovascular Medicine and Cerebrovascular Disease Prevention

Mahmoud R Azarpazhooh, MD

Role: PRINCIPAL_INVESTIGATOR

Western University, Canada

Reza Behrouz, DO

Role: PRINCIPAL_INVESTIGATOR

The University of Texas Health Science Center at San Antonio

Luca Masotti, MD

Role: PRINCIPAL_INVESTIGATOR

Azienda USL Reggio Emilia - IRCCS

Adrian R Parry-Jones, MBChB, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Manchester and the Salford Royal NHS Foundation Trust

Aurel Popa-Wagner, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Rostock

Mark A Slevin, PhD

Role: PRINCIPAL_INVESTIGATOR

Manchester Metropolitan University

Craig J Smith, MBChB, MD

Role: PRINCIPAL_INVESTIGATOR

University of Manchester and the Salford Royal NHS Foundation Trust

Daniel A Godoy, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital Interzonal de Agudos San Juan Bautista

Floris H Schreuder, MD

Role: PRINCIPAL_INVESTIGATOR

Maastricht University Medical Center

Michael W Hoffmann, MBChB, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Central Florida

References

Explore related publications, articles, or registry entries linked to this study.

Behrouz R, Azarpazhooh MR, Godoy DA, Hoffmann MW, Masotti L, Parry-Jones AR, Popa-Wagner A, Schreuder FH, Slevin MA, Smith CJ, Di Napoli M; MNEMONICH Steering Committee. The Multi-National survey on Epidemiology, Morbidity, and Outcomes iN Intracerebral Haemorrhage (MNEMONICH). Int J Stroke. 2015 Dec;10(8):E86. doi: 10.1111/ijs.12629. No abstract available.

Reference Type BACKGROUND
PMID: 26745705 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HSC20150655H

Identifier Type: -

Identifier Source: org_study_id